Home > Insider Trading > Filing (0000905718-14-000303)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1261249	Agile Therapeutics Inc	AGRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
889232	Ab Investor	C/O Investor Growth Capital, Llc One Rockefeller Plaza, Suite 2801 New York NY 10020		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2014-05-22	1,000,000	$6.00	1,000,000	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnotes

Footnotes

As of May 27, 2014 (the "Filing Date"), certain affiliated entities of Investor AB, a publicly held Swedish company (the "Reporting Person"), (i) beneficially own 1,000,000 shares of common stock, $0.0001 par value per share (the "Common Shares"), of Agile Therapeutics, Inc., a Delaware corporation (the "Company") and (ii) beneficially own 1,950,200 shares of the Company's Series B Preferred Stock, 424,557 shares of the Company's Series C Preferred Stock, and 135,192 of the Company's 8% Convertible Promissory Notes which are automatically convertible into an aggregate of 2,509,949 Common Shares upon the closing of the Company's initial public offering.
As a result of the foregoing, the Reporting Person, through one or more intermediate entities, possesses the sole power to vote and the sole power to direct the disposition of the Common Shares reported herein. Accordingly, the Reporting Person, as of the Filing Date, may be deemed to beneficially own an aggregate of 3,509,949 Common Shares.
The Reporting Person interest in the Common Shares reported herein is limited to its pecuniary interest, if any, in such Common Shares.